HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Progressive and regressive fate of lens tumors correlates with subtle differences in transgene expression in gamma F-crystallin-SV40 T antigen transgenic mice.

Abstract
Regulatory elements of the mouse gamma F-crystallin gene were used to derive transgenic mice expressing SV40 large T antigen in terminally differentiating fiber cells of the ocular lens. The resulting gamma F-crystallin-T antigen mice developed either malignant or regressive lens tumors in a strain-dependent fashion. Developmental and RNA analyses revealed that in both 'tumor-progressing' and 'tumor-regressing' mouse strains expression of the transgene blocked morphological differentiation of lens fibers without appreciably affecting gamma-crystallin gene expression, a marker of terminal lens fiber cell differentiation. Strain-dependent differences in tumorigenic outcome could be correlated with both subtle differences in transgene expression and the ability of tumor cells to escape from the normal confines of the lens. The results implicate the importance of cellular environment to malignant tumor development and provide insight into those features of normal lens ontogeny that may render the lens refractory to the development of spontaneous tumors.
AuthorsD M Bryce, Q Liu, W Khoo, L C Tsui, M L Breitman
JournalOncogene (Oncogene) Vol. 8 Issue 6 Pg. 1611-20 (Jun 1993) ISSN: 0950-9232 [Print] England
PMID8389033 (Publication Type: Journal Article)
Chemical References
  • Antigens, Polyomavirus Transforming
  • Crystallins
Topics
  • Animals
  • Animals, Newborn
  • Antigens, Polyomavirus Transforming (biosynthesis, genetics)
  • Crystallins (biosynthesis, genetics)
  • Eye Neoplasms (genetics, pathology)
  • Female
  • Gene Expression
  • In Situ Hybridization
  • Lens Diseases (genetics, pathology)
  • Male
  • Mice
  • Mice, Inbred Strains
  • Mice, Transgenic
  • Restriction Mapping
  • Simian virus 40 (genetics)
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: